"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Descriptor ID |
D006086
|
| MeSH Number(s) |
C20.452
|
| Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 4 | 3 | 7 |
| 1994 | 6 | 7 | 13 |
| 1995 | 4 | 8 | 12 |
| 1996 | 5 | 10 | 15 |
| 1997 | 4 | 7 | 11 |
| 1998 | 2 | 4 | 6 |
| 1999 | 5 | 12 | 17 |
| 2000 | 8 | 12 | 20 |
| 2001 | 5 | 11 | 16 |
| 2002 | 5 | 7 | 12 |
| 2003 | 4 | 14 | 18 |
| 2004 | 6 | 18 | 24 |
| 2005 | 7 | 13 | 20 |
| 2006 | 22 | 10 | 32 |
| 2007 | 12 | 18 | 30 |
| 2008 | 4 | 10 | 14 |
| 2009 | 15 | 9 | 24 |
| 2010 | 13 | 14 | 27 |
| 2011 | 14 | 22 | 36 |
| 2012 | 20 | 15 | 35 |
| 2013 | 8 | 7 | 15 |
| 2014 | 16 | 13 | 29 |
| 2015 | 14 | 18 | 32 |
| 2016 | 10 | 19 | 29 |
| 2017 | 14 | 21 | 35 |
| 2018 | 17 | 18 | 35 |
| 2019 | 19 | 11 | 30 |
| 2020 | 20 | 5 | 25 |
| 2021 | 34 | 6 | 40 |
| 2022 | 32 | 0 | 32 |
| 2023 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Engineering T cells to suppress acute GVHD and?leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2023 Mar 09; 141(10):1194-1208.
-
Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future. Stem Cells Transl Med. 2023 Mar 03; 12(2):55-71.
-
Effective treatment of low-risk acute GVHD with?itacitinib monotherapy. Blood. 2023 02 02; 141(5):481-489.
-
NCCN Guidelines? Insights: Hematopoietic Cell Transplantation, Version 3.2022. J Natl Compr Canc Netw. 2023 02; 21(2):108-115.
-
Effective T-cell replete haploidentical stem cell transplantation for pediatric patients with high-risk hematologic disorders. Eur J Haematol. 2023 Mar; 110(3):305-312.
-
HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection. Transplant Cell Ther. 2023 Mar; 29(3):189-198.
-
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2023 Mar; 29(3):151-163.
-
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study. Haematologica. 2022 10 01; 107(10):2496-2500.
-
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease. Cell. 2022 09 29; 185(20):3705-3719.e14.
-
Global perspectives on cellular therapy for children with sickle cell disease. Curr Opin Hematol. 2022 11 01; 29(6):275-280.